首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   23131篇
  免费   1850篇
  国内免费   76篇
耳鼻咽喉   389篇
儿科学   812篇
妇产科学   374篇
基础医学   2374篇
口腔科学   523篇
临床医学   2065篇
内科学   5091篇
皮肤病学   545篇
神经病学   1263篇
特种医学   1085篇
外国民族医学   1篇
外科学   4514篇
综合类   322篇
一般理论   15篇
预防医学   1114篇
眼科学   794篇
药学   2021篇
中国医学   37篇
肿瘤学   1718篇
  2023年   196篇
  2022年   182篇
  2021年   887篇
  2020年   473篇
  2019年   814篇
  2018年   942篇
  2017年   610篇
  2016年   645篇
  2015年   670篇
  2014年   1010篇
  2013年   1178篇
  2012年   1739篇
  2011年   1708篇
  2010年   866篇
  2009年   811篇
  2008年   1276篇
  2007年   1205篇
  2006年   1122篇
  2005年   976篇
  2004年   878篇
  2003年   747篇
  2002年   643篇
  2001年   583篇
  2000年   549篇
  1999年   480篇
  1998年   145篇
  1997年   118篇
  1996年   125篇
  1995年   139篇
  1994年   113篇
  1993年   97篇
  1992年   267篇
  1991年   284篇
  1990年   248篇
  1989年   212篇
  1988年   208篇
  1987年   219篇
  1986年   192篇
  1985年   177篇
  1984年   111篇
  1983年   125篇
  1982年   85篇
  1981年   70篇
  1979年   129篇
  1978年   77篇
  1977年   68篇
  1975年   58篇
  1974年   65篇
  1973年   88篇
  1970年   58篇
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
1.
2.
3.
Cheryl L. Rock PhD  RD  Cynthia A. Thomson PhD  RD  Kristen R. Sullivan MS  MPH  Carol L. Howe MD  MLS  Lawrence H. Kushi ScD  Bette J. Caan DrPH  Marian L. Neuhouser PhD  RD  Elisa V. Bandera MD  PhD  Ying Wang PhD  Kimberly Robien PhD  RD  Karen M. Basen-Engquist PhD  MPH  Justin C. Brown PhD  Kerry S. Courneya PhD  Tracy E. Crane PhD  RDN  David O. Garcia PhD  FACSM  Barbara L. Grant MS  RDN  CSO  FAND  Kathryn K. Hamilton MA  RDN  CSO  CDN  FAND  Sheri J. Hartman PhD  Stacey A. Kenfield ScD  Maria Elena Martinez PhD  Jeffrey A. Meyerhardt MD  MPH  Larissa Nekhlyudov MD  MPH  Linda Overholser MD  Alpa V. Patel PhD  Bernardine M. Pinto PhD  Mary E. Platek PhD  RD  CDN  Erika Rees-Punia PhD  MPH  Colleen K. Spees PhD  MEd  RD  LD  FAND  Susan M. Gapstur PhD  Marjorie L. McCullough ScD  RD 《CA: a cancer journal for clinicians》2022,72(3):230-262
The overall 5-year relative survival rate for all cancers combined is now 68%, and there are over 16.9 million survivors in the United States. Evidence from laboratory and observational studies suggests that factors such as diet, physical activity, and obesity may affect risk for recurrence and overall survival after a cancer diagnosis. The purpose of this American Cancer Society guideline is to provide evidence-based, cancer-specific recommendations for anthropometric parameters, physical activity, diet, and alcohol intake for reducing recurrence and cancer-specific and overall mortality. The audiences for this guideline are health care providers caring for cancer survivors as well as cancer survivors and their families. The guideline is intended to serve as a resource for informing American Cancer Society programs, health policy, and the media. Sources of evidence that form the basis of this guideline are systematic literature reviews, meta-analyses, pooled analyses of cohort studies, and large randomized clinical trials published since 2012. Recommendations for nutrition and physical activity during cancer treatment, informed by current practice, large cancer care organizations, and reviews of other expert bodies, are also presented. To provide additional context for the guidelines, the authors also include information on the relationship between health-related behaviors and comorbidities, long-term sequelae and patient-reported outcomes, and health disparities, with attention to enabling survivors' ability to adhere to recommendations. Approaches to meet survivors' needs are addressed as well as clinical care coordination and resources for nutrition and physical activity counseling after a cancer diagnosis.  相似文献   
4.
Detailed contemporary knowledge of the characteristics of the surgical population, national anaesthetic workload, anaesthetic techniques and behaviours are essential to monitor productivity, inform policy and direct research themes. Every 3–4 years, the Royal College of Anaesthetists, as part of its National Audit Projects (NAP), performs a snapshot activity survey in all UK hospitals delivering anaesthesia, collecting patient-level encounter data from all cases under the care of an anaesthetist. During November 2021, as part of NAP7, anaesthetists recorded details of all cases undertaken over 4 days at their site through an online survey capturing anonymous patient characteristics and anaesthetic details. Of 416 hospital sites invited to participate, 352 (85%) completed the activity survey. From these, 24,177 reports were returned, of which 24,172 (99%) were included in the final dataset. The work patterns by day of the week, time of day and surgical specialty were similar to previous NAP activity surveys. However, in non-obstetric patients, between NAP5 (2013) and NAP7 (2021) activity surveys, the estimated median age of patients increased by 2.3 years from median (IQR) of 50.5 (28.4–69.1) to 52.8 (32.1–69.2) years. The median (IQR) BMI increased from 24.9 (21.5–29.5) to 26.7 (22.3–31.7) kg.m–2. The proportion of patients who scored as ASA physical status 1 decreased from 37% in NAP5 to 24% in NAP7. The use of total intravenous anaesthesia increased from 8% of general anaesthesia cases to 26% between NAP5 and NAP7. Some changes may reflect the impact of the COVID-19 pandemic on the anaesthetic population, though patients with confirmed COVID-19 accounted for only 149 (1%) cases. These data show a rising burden of age, obesity and comorbidity in patients requiring anaesthesia care, likely to impact UK peri-operative services significantly.  相似文献   
5.
6.
7.
Journal of Neuro-Oncology - Primary central nervous system lymphoma (PCNSL) is a subtype of non-Hodgkin’s lymphoma that involves the brain, spinal cord, or leptomeninges, without evidence of...  相似文献   
8.
ABSTRACT

Fine and ultra-fine particulate matter (PM) are major constituents of urban air pollution and recognized risk factors for cardiovascular diseases. This review examined the effects of PM exposure on vascular tissue. Specific mechanisms by which PM affects the vasculature include inflammation, oxidative stress, actions on vascular tone and vasomotor responses, as well as atherosclerotic plaque formation. Further, there appears to be a greater PM exposure effect on susceptible individuals with pre-existing cardiovascular conditions.  相似文献   
9.
10.

Background

Epidemiology of patients with worsening heart failure and reduced ejection fraction (HFrEF) in the real-world setting is not well described.

Objectives

The purpose of this study was to describe incidence, clinical characteristics, treatment, and outcomes of patients with HFrEF who develop worsening heart failure (HF) in the real-world setting.

Methods

Data on patients with incident HFrEF from the National Cardiovascular Data Registry PINNACLE were linked to pharmacy, private practitioner, and hospital claims databases. Incidence, clinical characteristics, treatment (angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, beta-blocker, and mineralocorticoid receptor antagonist) and outcomes of patients with worsening HF, defined as ≥90 days of stable HF with subsequent worsening requiring intravenous diuretic agents, were assessed.

Results

Of 11,064 HFrEF patients, 1,851 (17%) developed worsening HF on average 1.5 years following initial HF diagnosis. Patients who developed worsening HF were more likely to be African American, be octogenarians, and have higher comorbidity burden (p < 0.001). At the onset of worsening HF, 42.4% of patients were on monotherapy, 43.4% were on dual therapy, and 14.1% were on triple therapy. A total of 48%, 61%, and 98% of patients were on >50% target dose for angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, beta-blocker, and mineralocorticoid receptor antagonist, respectively. The 2-year mortality rate was 22.5%, and 56% of patients were rehospitalized within 30 days of the worsening HF event.

Conclusions

In the real-world setting, 1 in 6 patients with HFrEF develop worsening HF within 18 months of HF diagnosis. These patients have a high risk for 2-year mortality and recurrent HF hospitalizations. The use of standard-of-care therapies both before and after the onset of worsening HF is low. With high unmet medical need, patients with worsening HF require novel treatment strategies as well as greater optimization of existing guideline-directed therapy.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号